PDCD1 and neoplasm: For instance, previous studies reported that LAG-3 and PD-1 were co-expressed on tumor-infiltrating lymphocytes, and blockade of both pathways had synergistic effects on anti-tumor CD8+ T cell stimulation and response (40, 41).